Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children
Authors
Keywords
-
Journal
PEDIATRIC DRUGS
Volume 19, Issue 6, Pages 523-531
Publisher
Springer Nature
Online
2017-08-14
DOI
10.1007/s40272-017-0257-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
- (2017) Ting Shi et al. LANCET
- Broadening Horizons: New Antibodies Against Influenza
- (2016) Katherine J.L. Jackson et al. CELL
- Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
- (2016) M. Gordon Joyce et al. CELL
- Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes
- (2016) Nicole L. Kallewaard et al. CELL
- Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis
- (2016) Kathleen Winter et al. CLINICAL INFECTIOUS DISEASES
- M2-based influenza vaccines: recent advances and clinical potential
- (2016) Annasaheb Kolpe et al. Expert Review of Vaccines
- Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals
- (2016) Li Liu et al. LANCET
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Haidong Wang et al. LANCET
- Influenza Vaccine Effectiveness and Uptake in Children at Risk of Severe Disease
- (2016) Christopher C. Blyth et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials
- (2016) Aye M. Moa et al. VACCINE
- Advances in RSV vaccine research and development – A global agenda
- (2016) Deborah Higgins et al. VACCINE
- Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
- (2016) et al. JAMA Pediatrics
- Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
- (2015) Lindsay Broadbent et al. Influenza and Other Respiratory Viruses
- Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults
- (2015) Christopher A. Green et al. Science Translational Medicine
- Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
- (2014) Miguel A. Rodriguez Weber et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age
- (2014) David P. Greenberg et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Effectiveness of Trivalent Flu Vaccine in Healthy Young Children
- (2014) C. C. Blyth et al. PEDIATRICS
- Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection
- (2014) PEDIATRICS
- Modelling the Seasonal Epidemics of Respiratory Syncytial Virus in Young Children
- (2014) Hannah C. Moore et al. PLoS One
- Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age
- (2014) Natasha B. Halasa et al. Journal of the Pediatric Infectious Diseases Society
- Traditional and New Influenza Vaccines
- (2013) S.-S. Wong et al. CLINICAL MICROBIOLOGY REVIEWS
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 Years
- (2013) Joseph B. Domachowske et al. JOURNAL OF INFECTIOUS DISEASES
- Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis
- (2013) Harish Nair et al. LANCET
- Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
- (2013) Elissa Malkin et al. PLoS One
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- (2012) M. Magro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
- (2012) Carrie Reed et al. VACCINE
- Viral vectors as vaccine platforms: deployment in sight
- (2011) Christine S Rollier et al. CURRENT OPINION IN IMMUNOLOGY
- Respiratory syncytial virus vaccine development
- (2011) Julia L Hurwitz Expert Review of Vaccines
- Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis
- (2011) Harish Nair et al. LANCET
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children
- (2011) Timo Vesikari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
- (2011) David I. Bernstein et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants
- (2011) David I. Bernstein et al. VACCINE
- The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
- (2011) Christopher S. Ambrose et al. VACCINE
- Progress in the development of human parainfluenza virus vaccines
- (2011) Alexander C Schmidt et al. Expert Review of Respiratory Medicine
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
- (2010) Barney S. Graham IMMUNOLOGICAL REVIEWS
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
- (2010) Harish Nair et al. LANCET
- Parainfluenza Virus Infection of Young Children: Estimates of the Population-Based Burden of Hospitalization
- (2009) Geoffrey A. Weinberg et al. JOURNAL OF PEDIATRICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started